Axogen (AXGN) Debt to Equity (2010 - 2025)
Axogen's quarterly Debt to Equity came in at $0.38 in Q4 2025, down 17.84% year-on-year from $0.46 in Q4 2024, and down 5.8% quarter-over-quarter from $0.4 in Q3 2025.
Axogen has reported Debt to Equity for 16 years, with the latest figure at $0.38 in Q4 2025.
- For the quarter ending Q4 2025, Debt to Equity fell 17.84% year-over-year to $0.38; the trailing twelve-month figure through Dec 2025 stood at $0.38 (down 17.84% YoY), and the FY2025 full-year result was $0.38, down 17.84% from the prior year.
- Debt to Equity for Q4 2025 stood at $0.38, down from $0.4 in the prior quarter.
- The five-year high for Debt to Equity was $0.5 in Q1 2024, with the low at $0.27 in Q1 2021.
- Average Debt to Equity over 5 years is $0.44, with a median of $0.45 recorded in 2022.
- Year-over-year, Debt to Equity soared 1021.24% in 2021 and slipped 17.84% in 2025.
- Tracing AXGN's Debt to Equity over 5 years: stood at $0.4 in 2021, then advanced by 13.65% to $0.45 in 2022, then grew by 7.63% to $0.49 in 2023, then fell by 6.17% to $0.46 in 2024, then decreased by 17.84% to $0.38 in 2025.
- The last three Debt to Equity figures came in at $0.38 (Q4 2025), $0.4 (Q3 2025), and $0.43 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.65 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.64 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.57 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.42 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.06 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.95 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.27 |
| 10 | Axogen | 2.00 Bn | 1.90 Bn | 46.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.38 |
| Sep 30, 2025 | 0.40 |
| Jun 30, 2025 | 0.43 |
| Mar 31, 2025 | 0.45 |
| Dec 31, 2024 | 0.46 |
| Sep 30, 2024 | 0.48 |
| Jun 30, 2024 | 0.49 |
| Mar 31, 2024 | 0.50 |
| Dec 31, 2023 | 0.49 |
| Sep 30, 2023 | 0.47 |
| Jun 30, 2023 | 0.48 |
| Mar 31, 2023 | 0.47 |
| Dec 31, 2022 | 0.45 |
| Sep 30, 2022 | 0.45 |
| Jun 30, 2022 | 0.45 |
| Mar 31, 2022 | 0.43 |
| Dec 31, 2021 | 0.40 |
| Sep 30, 2021 | 0.40 |
| Jun 30, 2021 | 0.39 |
| Mar 31, 2021 | 0.27 |
| Dec 31, 2020 | 0.26 |
| Sep 30, 2020 | 0.18 |
| Mar 31, 2020 | 0.02 |
| Dec 31, 2019 | 0.01 |
| Sep 30, 2019 | 0.03 |
| Jun 30, 2019 | 0.03 |
| Mar 31, 2019 | 0.03 |
| Dec 31, 2018 | 0.00 |
| Sep 30, 2018 | 0.00 |
| Jun 30, 2018 | 0.00 |
| Mar 31, 2018 | 1.00 |
| Dec 31, 2017 | 0.82 |
| Sep 30, 2017 | 2.31 |
| Jun 30, 2017 | 2.13 |
| Mar 31, 2017 | 2.00 |
| Dec 31, 2016 | 1.36 |
| Sep 30, 2016 | 22.65 |
| Jun 30, 2016 | 8.93 |
| Mar 31, 2016 | 5.13 |
| Dec 31, 2015 | 3.01 |
| Sep 30, 2015 | 2.29 |
| Jun 30, 2015 | -7.20 |
| Mar 31, 2015 | -37.13 |
| Dec 31, 2014 | -2.23 |
| Sep 30, 2014 | -2.77 |
| Jun 30, 2014 | -3.80 |
| Mar 31, 2014 | -7.11 |
| Dec 31, 2013 | 185.63 |
| Sep 30, 2013 | 5.91 |
| Jun 30, 2013 | -2.51 |
| Mar 31, 2013 | -3.74 |
| Dec 31, 2012 | -7.63 |
| Sep 30, 2012 | 2.37 |
| Jun 30, 2012 | 1.49 |
| Mar 31, 2012 | 1.18 |
| Dec 31, 2011 | 0.80 |
| Sep 30, 2011 | 0.61 |
| Dec 31, 2010 | -0.26 |